S212: PHASE I STUDY OF YTB323, A CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELL THERAPY MANUFACTURED USING T-CHARGE™, IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

Bibliographic Details
Main Authors:	M. Dickinson, M. Kwon, J. Briones, U. Jäger, K. Kato, E. Bachy, D. Blaise, N. Boissel, N. Shah, M Frigault, P. Riedell, L. Shune, T. Teshima, X. Zhu, E. Orlando, L. Yi, J. Davis, E. Bleickardt, I. Flinn, P. Barba
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000843740.59934.f7

Internet